Insider · CIK 0002121196
Rafael Bergman
Files at CSAN (Cosan Ltd.), CSANY (Cosan S.A.). First filing -, latest -.
Rafael Bergman files SEC Form 4 as insider at CSAN (Cosan Ltd.), and also at CSANY (Cosan S.A.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rafael Bergman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | CSAN Cosan Ltd. | JOther COMMON STOCK (BVMF: CSAN3) | +55,242 | $3.90 | $215k | 272,714 | 28 d ago |
| Sep 11, 2026 | CSANY Cosan S.A. | JOther COMMON STOCK (BVMF: CSAN3) | +55,242 | $3.90 | $215k | 272,714 | 28 d ago |
| Sep 11, 2026 | CSAN Cosan Ltd. | JOther LONG TERM INCENTIVE (BVMF: CSAN3) | -55,242 | $3.90 | $215k | 0 | 28 d ago |
| Sep 11, 2026 | CSANY Cosan S.A. | JOther LONG TERM INCENTIVE (BVMF: CSAN3) | -55,242 | $3.90 | $215k | 0 | 28 d ago |
Questions about Rafael Bergman
Answered from the filings on this page, as of the latest one.
Is Rafael Bergman buying or selling?
Rafael Bergman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rafael Bergman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rafael Bergman has 0.
Where does Rafael Bergman file Form 4?
Rafael Bergman has filed Form 4 at CSAN (Cosan Ltd.); CSANY (Cosan S.A.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.